Stay updated on Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-13T19:14:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 with no visible changes to page content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:45:19.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.4.1 has been added and Revision: v3.4.0 has been removed.
    Difference
    0.1%
    Check dated 2026-02-04T23:14:39.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows a glossary and includes a new 'Last Update Submitted that Met QC Criteria' field, along with a 'No FEAR Act Data' notice and an updated site revision 'Revision: v3.4.0'. Previously displayed items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T20:06:13.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:45:38.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added the Locations section listing Texas and UT Southwestern Medical Center as study sites, and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure, as well as Texas Locations and UT Southwestern Medical Center entries, with a revision to v3.3.2.
    Difference
    0.3%
    Check dated 2025-12-23T21:33:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Anaplastic/Undifferentiated Thyroid Cancer Clinical Trial page.